Pharmanutra S.p.A.

Milan Stock Exchange PHN.MI

Pharmanutra S.p.A. Return on Assets (ROA) for the year ending December 31, 2023: 11.41%

Pharmanutra S.p.A. Return on Assets (ROA) is 11.41% for the year ending December 31, 2023, a -24.05% change year over year. Return on assets measures profitability against assets; higher ROA indicates efficient asset use and profitability.

Pharmanutra S.p.A. Return on Assets (ROA) for the year ending December 31, 2022 was 15.02%, a -22.15% change year over year.
Pharmanutra S.p.A. Return on Assets (ROA) for the year ending December 31, 2021 was 19.30%, a -29.08% change year over year.
Pharmanutra S.p.A. Return on Assets (ROA) for the year ending December 31, 2020 was 27.21%, a 57.30% change year over year.
Pharmanutra S.p.A. Return on Assets (ROA) for the year ending December 31, 2019 was 17.30%, a -16.15% change year over year.

Key data

Date	Return on Assets (ROA)	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio

Milan Stock Exchange: PHN.MI

Pharmanutra S.p.A.

CEO	Mr. Andrea Lacorte
IPO Date	July 18, 2017
Location	Italy
Headquarters	Via delle Lenze 216/B
Employees	112
Sector	Healthcare
Industries Pharmaceuticals Baby & Childcare Cosmetics Dairy & Milk Drugstores & Retail Pharmacies Personal Care Pet Food Snack Foods

Description

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.

Key trends

Past 5 years